Angioplasty and transplantation
Angioplasty and transplantation are two treatment options for individuals with a narrowing of the venal cavity. When doctors diagnose atherosclerosis, they may opt for angioplasty, a minimally invasive procedure. During angioplasty, a deflated balloon is inserted into the vein and then inflated to open up the channel and improve hepatic blood flow. In some cases, doctors may choose to use a stent to clear out the blockage instead.
However, there are situations where liver failure progresses rapidly, and cirrhosis reaches a point where life expectancy is a year or less. In such severe cases, a liver transplant becomes the best available option. Through transplantation, a healthy liver is surgically replaced with a diseased one to restore normal liver function and improve the patient’s prognosis.
Life Expectancy
When it comes to Budd-Chiari syndrome, doctors rely on a specific formula to determine the prognosis for affected individuals. This formula, known as the PI (Prognostic Index), takes into consideration several factors including ascites, age, Pugh score, and creatinine level. By using the PI formula, doctors can gauge the likelihood of a positive outcome for patients with this syndrome. A score of 5.4 or lower indicates a good prognosis.
For individuals who have undergone shunt procedures, the five-year survival rate falls between 38 and 87 percent. Meanwhile, those who have received liver transplants have a higher five-year survival rate of 70%. On average, the ten-year survival rate for people with Budd-Chiari syndrome is approximately 55 percent.
It’s important to note that if left untreated, Budd-Chiari syndrome can significantly reduce life expectancy. In fact, for individuals with untreated BCS, the survival rate ranges from three months to three years from the time of diagnosis.